Trovagene, Inc., a developer of cell-free molecular diagnostics, has entered into an agreement with FedMed, Inc. (FedMed) establishing health benefit access to Trovagene's full line of Precision Cancer Monitoring (PCM) tests and services.

Under the agreement, Trovagene's PCM services are covered as a participating laboratory testing provider for clients of FedMed, which include major health insurers such as Aetna, Cigna and Humana, and encompasses over 550,000 in-network physicians nationwide.

"A major focus of FedMed is to provide innovative solutions for the healthcare community, particularly in areas such as cancer, where there is a high need to improve patient care and deliver that care in an efficient manner," said Brian Moffitt, chief operating officer of FedMed. "In line with our core strategy, we are extremely pleased to offer Trovagene's non-invasive, clinically actionable tests and services to oncologists and their patients within our national provider network."

"FedMed is among the largest national provider networks in the country, and this agreement is an important step in our ability to offer oncologists and their patients access to our liquid biopsy testing services through their health benefit plans," said Matt Posard, chief commercial officer of Trovagene. "We're very pleased with the positive response we are receiving from national provider networks, validating our decision to design the PCM platform to report on clinically actionable cancer genes that can translate into clear use scenarios and better reimbursement outcomes.  We remain committed to creating a strong foundation of studies demonstrating the multiple clinical utilities of our technology, which we believe will broaden health insurance coverage and patient access this year."

Founded in 2000 and headquartered in Gaithersburg, Maryland, FedMed, Inc. operates a proprietary Preferred Provider Organization consisting of over 550,000 physicians, 4,000 hospitals and 60,000 ancillary care providers nationwide. FedMed's client list includes insurance companies, third party administrators (TPAs), self- administered employer groups, taft-hartley funds, student programmes and international programmes.